Search Medical Condition
Please enter condition
Please choose location
 

Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1215) clinical trials

This is a placebo controlled trial to test the efficacy and safety of CHF 5259 (glycopyrronium bromide). This is an 8 week treatment trial.

Phase

A global registry to study the demographics, socioeconomic and clinical factors, etiologies, pathophysiology, management, barriers to care, and outcomes of heart failure patients.

Phase N/A

Diagnosis of Individuals With Pulmonary Nodules by Different Bronchoscopy Combination

This study evaluates the value of different bronchoscopy combination for diagnosing peripheral pulmonary lesions suspected to be cancer. One-third of participants will receive routine bronchoscopy, while one-third of participants will receive bronchoscopy combined with a guiding equipment and the other one-third of participants will receive bronchoscopy combined with two or ...

Phase N/A

A Phase 2a Study to Assess Safety Daily Symptoms Pharmacokinetics (PK) and Biomarkers of YPL-001 in Chronic Obstructive Pulmonary Disease (COPD) Patients

This is a Phase 2a, proof-of-concept, multicenter, randomized, double-blind, double dummy, 3-treatment, parallel study, with low and high YPL 001 doses (low dose and high dose twice daily [BID]) and a placebo control in moderate to severe Chronic Obstructive Pulmonary Disease (COPD) patients.

Phase

Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer

PRIMARY OBJECTIVES: I. To perform comprehensive genomic analysis of young lung cancer patients' samples to facilitate delivery of targeted therapies and clinical trial enrollment. II. To characterize the impact of young age at lung cancer diagnosis on the genomic landscape of primary lung cancer. III. To establish a prospective registry ...

Phase N/A

NovellusDx Functional Profiling of Oncogenic Mutations in Lung Cancer Patients

NovellusDx technology identifies tumor-specific driver mutations, but unlike sequencing-based tests, NovellusDx has a functional assay that detects dis-regulated translocation of mutated signaling proteins to the nucleus. This allows NovellusDx to identify functionally-impactful driver mutations regardless of whether the mutation has previously been described or linked to a tumor type.

Phase N/A

Safety Tolerability Pharmacokinetics and Anti-tumour Activity of AC0010 in Advanced Non Small Cell Lung Cancer

This study will treat patients with advanced NSCLC who have already received at least one course of specific anti-cancer treatment but the tumor has started to re-grow following that treatment. This is the first time that this drug is used or tested in patients, and so it will help to ...

Phase

Innovations in Treating COPD Exacerbations: Pilot Project on Action Plans Using New Technology.

BACKGROUND: Chronic Obstructive Pulmonary Disease (COPD) is the 4th leading cause of death in Canada and the only chronic disease where mortality rates continue to climb. Acute exacerbations are common.Unfortunately, exacerbations are often viewed as trivial events or "simple bronchitis"despite being linked with accelerated lung function decline, poor health, hospital ...

Phase N/A

Low Load High-repetitive Elastic Band Resistance Training in COPD

Recent work have shown that low load, high-repetitive single limb resistance training, if compared to a control, can increase limb muscle function and functional exercise capacity in patients with chronic obstructive pulmonary disease (COPD) while avoiding the occurrence of limiting exertional symptoms. However, no comparison to another exercise regimen have ...

Phase N/A

Blood Sample Monitoring of Patients With EGFR Mutated Lung Cancer

Background Non-small celled lung cancer (NSCLC) is one of the most common cancers in the world, and Denmark has one of the highest incidences of approximately 3800 new patients each year who are diagnosed with NSCLC, and the overall prognosis is very poor. The EGF (epidermal growth factor) system with ...

Phase N/A